Financials EOM Pharmaceuticals Holdings, Inc.

Equities

IMUC

US4525364026

Biotechnology & Medical Research

Market Closed - OTC Markets 07:10:05 10/05/2024 pm IST 5-day change 1st Jan Change
0.21 USD +40.00% Intraday chart for EOM Pharmaceuticals Holdings, Inc. +14.13% -9.48%

Valuation

Fiscal Period: December 2021
Capitalization 1 20.69
Enterprise Value (EV) 1 22.02
P/E ratio -3.82 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF -1,46,72,942 x
FCF Yield -0%
Price to Book -29.4 x
Nbr of stocks (in thousands) 49,271
Reference price 2 0.4200
Announcement Date 24/06/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021
Net sales - -
EBITDA - -
EBIT 1 -1.937 -2.613
Operating Margin - -
Earnings before Tax (EBT) 1 -1.937 -5.149
Net income 1 -1.937 -5.149
Net margin - -
EPS 2 -0.0387 -0.1100
Free Cash Flow - -1.501
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 10/02/22 24/06/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021
Net Debt 1 - 1.33
Net Cash position 1 0.26 -
Leverage (Debt/EBITDA) - -
Free Cash Flow - -1.5
ROE (net income / shareholders' equity) - 693%
ROA (Net income/ Total Assets) - -169%
Assets 1 - 3.047
Book Value Per Share 2 0 -0.0100
Cash Flow per Share 2 0.0100 0.0100
Capex - -
Capex / Sales - -
Announcement Date 10/02/22 24/06/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. IMUC Stock
  4. Financials EOM Pharmaceuticals Holdings, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW